MedTrace Logo

Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy

NCT00511056 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2020-07-17

No results posted yet for this study

Summary

Study Hypothesis: Do certain risk behaviours impact/predict levels of HIV antiretroviral adherence?

Objectives:

* To assess risk behavior in HIV-positive individuals receiving highly active antiretroviral therapy.(HAART)
* To assess levels of adherence in the same subjects at the same time point
* To determine if there is a correlation between HAART adherence and risk behaviour

Conditions

  • HIV Infections

Sponsors & Collaborators

  • Kirby Institute

    collaborator OTHER_GOV

  • The HIV Netherlands Australia Thailand Research Collaboration

    lead OTHER

Principal Investigators

  • Kiat Ruxrungtham, M.D., M.Sc. · HIVNAT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2009-01-31
Completion
2009-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00511056 on ClinicalTrials.gov